|
|
 |
|
Healthcare-acquired, antibiotic-resistant infections kill 8,000 Canadian patients each year.1,2 They cost patients an average 39 extra days in the hospital2and healthcare systems at least US$100 million annually.1,2 Meanwhile, controlling the source of these harmful organisms on patients’ skin is a key component in reducing transmission between patients, staff, visitors and the healthcare environment.3,4
For patients at risk for healthcare-acquired infections (HAIs)—including those known or suspected to be colonized by resistant organisms—there is a new method of skin decolonization. Antiseptic body cleansing with 2% chlorhexidine gluconate (CHG) washcloths has been proven effective against a wide range of pathogens, including methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant enterococci (VRE), acinetobacter baumannii and more.5
|
